沃森生物

- 300142

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2025  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015 
沃森生物(300142) 利润表
单位:万元
报表日期2025-09-302025-06-302025-03-312024-12-312024-09-30
一、营业总收入171,880.79115,421.2446,225.77282,144.13214,134.62
营业收入171,880.79115,421.2446,225.77282,144.13214,134.62
二、营业总成本148,830.0197,573.8042,665.05253,177.41175,603.15
营业成本48,652.7534,306.9413,181.5857,299.2944,062.43
营业税金及附加1,413.86948.16358.421,887.971,373.81
销售费用56,314.1437,660.1716,433.7997,883.0768,070.08
管理费用27,062.5617,028.227,077.9742,154.9821,991.31
财务费用-6,183.58-4,449.97-1,077.08-5,702.38-3,005.02
研发费用21,570.2812,080.286,690.3759,654.4743,110.54
资产减值损失----------
公允价值变动收益9,180.031,342.231,413.73-9,833.91-9,369.01
投资收益278.36-48.61-13.63502.59489.69
其中:对联营企业和合营企业的投资收益-66.08-48.61-13.6313.017.48
汇兑收益----------
三、营业利润14,035.361,392.83-1,357.619,667.4128,608.30
加:营业外收入71.6668.2465.8712,692.5712,692.41
减:营业外支出479.16256.81185.293,909.773,921.79
其中:非流动资产处置损失----------
四、利润总额13,627.861,204.25-1,477.0218,450.2137,378.92
减:所得税费用3,276.571,913.67491.251,010.422,314.83
五、净利润10,351.29-709.42-1,968.2717,439.7935,064.09
归属于母公司所有者的净利润16,344.294,316.06264.6214,216.0425,635.86
少数股东损益-5,993.00-5,025.49-2,232.893,223.759,428.23
六、每股收益
基本每股收益(元/股)0.10220.02730.00170.08890.1603
稀释每股收益(元/股)0.10220.02730.00170.08890.1603
七、其他综合收益10,625.003,995.00---4,590.00--
八、综合收益总额20,976.293,285.58-1,968.2712,849.7935,064.09
归属于母公司所有者的综合收益总额26,969.298,311.06264.629,626.0425,635.86
归属于少数股东的综合收益总额-5,993.00-5,025.49-2,232.893,223.759,428.23
下载全部历史数据到excel中 返回页顶